- Home
- XENE vs HSAI Comparison
XENE vs HSAI Comparison
Compare XENE & HSAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XENE
- HSAI
- Stock Information
- Founded
- XENE 1996
- HSAI 2014
- Country
- XENE Canada
- HSAI China
- Employees
- XENE N/A
- HSAI N/A
- Industry
- XENE Biotechnology: Pharmaceutical Preparations
- HSAI
- Sector
- XENE Health Care
- HSAI
- Exchange
- XENE Nasdaq
- HSAI Nasdaq
- Market Cap
- XENE 2.9B
- HSAI 2.8B
- IPO Year
- XENE 2014
- HSAI 2023
- Fundamental
- Price
- XENE $39.04
- HSAI $23.03
- Analyst Decision
- XENE Strong Buy
- HSAI Strong Buy
- Analyst Count
- XENE 10
- HSAI 4
- Target Price
- XENE $52.90
- HSAI $31.58
- AVG Volume (30 Days)
- XENE 795.3K
- HSAI 2.6M
- Earning Date
- XENE 11-03-2025
- HSAI 11-11-2025
- Dividend Yield
- XENE N/A
- HSAI N/A
- EPS Growth
- XENE N/A
- HSAI N/A
- EPS
- XENE N/A
- HSAI 0.11
- Revenue
- XENE $7,500,000.00
- HSAI $347,701,639.00
- Revenue This Year
- XENE N/A
- HSAI $61.81
- Revenue Next Year
- XENE $207.88
- HSAI $45.58
- P/E Ratio
- XENE N/A
- HSAI $218.74
- Revenue Growth
- XENE N/A
- HSAI 36.51
- 52 Week Low
- XENE $26.74
- HSAI $4.02
- 52 Week High
- XENE $46.00
- HSAI $30.85
- Technical
- Relative Strength Index (RSI)
- XENE 41.74
- HSAI 43.53
- Support Level
- XENE $37.63
- HSAI $22.04
- Resistance Level
- XENE $42.96
- HSAI $23.97
- Average True Range (ATR)
- XENE 1.60
- HSAI 0.95
- MACD
- XENE -0.47
- HSAI 0.07
- Stochastic Oscillator
- XENE 21.42
- HSAI 45.93
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
About HSAI Hesai Group each ADS represents one Class B ordinary share
Hesai Group is engaged in the development, manufacture, and sales of three-dimensional light detection and ranging solutions, or LiDAR. Its LiDAR products enable a broad spectrum of applications across passenger or commercial vehicles with enhanced advanced driver assistance systems, or ADAS, autonomous vehicle fleets providing passenger and freight mobility services, or Autonomous Mobility, and other applications such as last-mile delivery robots, street sweeping robots, and logistics robots in restricted areas, or Robotics. Geographically, the company operates in North America, Mainland China, Europe, and Other regions.